Medical device manufacturers are doubling down on the FDA, agreeing to pay $595 million in fees over 5 years in exchange for promises of more and faster approvals and better communication from the agency. That is about twice what was paid under the program that expires Sept. 30. The FDA said it will hire about 200 people to speed up the process, and an independent consultant to recommend process improvements. Release | Story